{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:14:54Z","timestamp":1777515294684,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bullous pemphigoid (BP) is a chronic immune-mediated vesiculobullous disorder. Recently, several reports have described dipeptidyl peptidase-4 inhibitors, also known as gliptins, as causative agents for drug-induced BP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To report and describe clinical and histologic characteristics of 10 cases of gliptin-induced BP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 10 patients with gliptin-induced BP. Nine were secondary to linagliptin, and 1 case was attributed to sitagliptin. All patients showed significant improvement after withdrawal of gliptin medications and proper medical treatment. There has been no evidence of relapse after 4 months of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report supports the proposed association between gliptins and BP. Physicians should be aware of this potential adverse effect, as gliptin-induced BP can be reversible once identified and the responsible medication is stopped. Early withdrawal of the offending drug and proper treatment can lead to rapid improvement and reduced morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1203475420972349","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T01:40:04Z","timestamp":1605145204000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Gliptin-Induced Bullous Pemphigoid: Canadian Case Series of 10 Patients"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-7368","authenticated-orcid":false,"given":"Miriam","family":"Armanious","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-2086","authenticated-orcid":false,"given":"Mohn\u2019d","family":"AbuHilal","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"bibr1-1203475420972349","volume-title":"StatPearls [Internet]","author":"Baigrie D.","year":"2020"},{"key":"bibr2-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.011"},{"key":"bibr3-1203475420972349","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00220"},{"key":"bibr4-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12366"},{"key":"bibr5-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2009.03.004"},{"key":"bibr6-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.034"},{"key":"bibr7-1203475420972349","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0409"},{"key":"bibr8-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4556"},{"key":"bibr9-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12397"},{"key":"bibr10-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.01.027"},{"key":"bibr11-1203475420972349","unstructured":"Canada, Health. Summary safety review \u2013 Dipeptidylpeptidase-4 inhibitors. Accessed June 15, 2017. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/safety-reviews\/summary-safety-review-dipeptidylpeptidase-4-inhibitors-assessing-potential-risk-heart-failure.html"},{"key":"bibr12-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.038"},{"key":"bibr13-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14601"},{"key":"bibr14-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.045"},{"key":"bibr15-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1159\/000443330"},{"key":"bibr16-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14245"},{"key":"bibr17-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2352"},{"key":"bibr18-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14658"},{"key":"bibr19-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01003-6"},{"key":"bibr20-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.023"},{"key":"bibr21-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.06.622"},{"key":"bibr22-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2019.07.003"},{"key":"bibr23-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.051"},{"key":"bibr24-1203475420972349","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01224"},{"key":"bibr25-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14005"},{"key":"bibr26-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16479"},{"key":"bibr27-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00109-3"},{"key":"bibr28-1203475420972349","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-9005-8"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475420972349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1203475420972349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475420972349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:54:45Z","timestamp":1777391685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1203475420972349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1177\/1203475420972349"],"URL":"https:\/\/doi.org\/10.1177\/1203475420972349","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]}}}